Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2986815 | 0.97 | TYR (0.52) | TYRMEN1TP53CYP3A4ALOX5 | |
| Zinc Ion SCHEMBL2984772 | 0.97 | TYR (0.52) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL2976423 | 0.97 | TYR (0.52) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL2987523 | 0.84 | TYR (0.55) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL2984775 | 0.83 | TYR (0.53) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL2979330 | 0.83 | TYR (0.53) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL2986817 | 0.83 | TYR (0.53) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL2978786 | 0.80 | TYR (0.50) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL3206953 | 0.76 | TYR (0.53) | TYR | |
| SCHEMBL2986681 | 0.75 | TYR (0.61) | TYRMEN1TP53CYP3A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7777073-B2 | Topical delivery system for antiaging and skin whitening agents | BIODERM RESEARCH (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | TYR 1/4885MEN1 4836/4885TP53 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.